The Effectiveness of Telerehabilitation in Improving Upper Extremity in Parkinson's Patients

May 25, 2022 updated by: Sefa Eldemir, Gazi University

The Effectiveness of Task-Oriented Training Based Telerehabilitation in Improving Upper Extremity Motor Function in Parkinson's Patients

Parkinson's Disease (PD) is a disease that affects the functional skills of the upper extremity with clinical findings such as bradykinesia, rigidity, and hypokinesia and causes limitations in the daily life activities of the patients. Task-oriented training (TOT) is a highly individualized, client-centered, occupational therapy, functional-based intervention compatible with motor learning and motor control principles such as intensive motor training, variable practice, and intermittent feedback. Few studies have been found on the TOT of the upper extremity in PD. Telerehabilitation of Parkinson's patients shows many strengths, such as cost-related and time-dependent ease, and the possibility of telecommunication with clinicians. In addition, the refinement of digital health solutions with the goal to offer a patient-tailored intervention remains an ongoing process. There are a limited number of studies on TOT and telerehabilitation of the upper extremity in PD. In addition, no studies have been found applying TOT through telerehabilitation. For this purpose, a study including TOT-based telerehabilitation in upper extremity education in PD was planned.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Balance and walking exercises consisting of 3 days a week for 6 weeks will be given to both groups as a home program. In addition, the exercise group will receive TOT-based telerehabilitation via video conferencing 3 days a week for 6 weeks. TOT will be formed from daily life activities such as reaching out, grasping, writing, and manual skills, which are frequently used in daily life. As the outcome measures, disease severity and disability, finger and hand function, hand strength, and quality of life will be evaluated.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 45- 70 years of age
  • Having diagnosed with "Parkinson's Disease" by a specialist physician
  • Having between 1-3 stages according to the Hoehn and Yahr Scale
  • Mini-Mental Test score more than or equal 24

Exclusion Criteria:

- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise group
The group that will receive task-oriented training via telerehabilitation
Both groups will receive exercise-based training
Placebo Comparator: Control group
The control group only will be given a home program that includes walking and balance exercises
Both groups will receive exercise-based training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manual dexterity performance - Baseline
Time Frame: Assessment will be conducted before the intervention
Nine Hole Peg test (9-HPT)
Assessment will be conducted before the intervention
Manual dexterity performance - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
Nine Hole Peg test (9-HPT)
Assessment will be conducted immediately after the intervention
Finger and hand function - Baseline
Time Frame: Assessment will be conducted before the intervention
Jebsen-Taylor Hand Function Test (JTHFT)
Assessment will be conducted before the intervention
Finger and hand function - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
Jebsen-Taylor Hand Function Test (JTHFT)
Assessment will be conducted immediately after the intervention
Upper extremity performance (coordination, dexterity and functioning) - Baseline
Time Frame: Assessment will be conducted before the intervention
Action Research Arm Test (ARAT)
Assessment will be conducted before the intervention
Upper extremity performance (coordination, dexterity and functioning) - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
Action Research Arm Test (ARAT)
Assessment will be conducted immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric hand strength - Baseline
Time Frame: Assessment will be conducted before the intervention
J-Tech ™
Assessment will be conducted before the intervention
Isometric hand strength - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
J-Tech ™
Assessment will be conducted immediately after the intervention
Isometric pinch strength - Baseline
Time Frame: Assessment will be conducted before the intervention
Baseline® pinch meter
Assessment will be conducted before the intervention
Isometric pinch strength - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
Baseline® pinch meter
Assessment will be conducted immediately after the intervention
Disease severity and disability - Baseline
Time Frame: Assessment will be conducted before the intervention
MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)
Assessment will be conducted before the intervention
Disease severity and disability - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)
Assessment will be conducted immediately after the intervention
Health-related Quality of Life - Baseline
Time Frame: Assessment will be conducted before the intervention
Parkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Assessment will be conducted before the intervention
Health-related Quality of Life - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
Parkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Assessment will be conducted immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Sefa Eldemir, PT, MSc., Research assistant
  • Study Director: Arzu Güçlü-Gündüz, PT, PhD., PROFESSOR

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2021

Primary Completion (Actual)

May 15, 2022

Study Completion (Actual)

May 25, 2022

Study Registration Dates

First Submitted

March 30, 2021

First Submitted That Met QC Criteria

April 6, 2021

First Posted (Actual)

April 8, 2021

Study Record Updates

Last Update Posted (Actual)

May 27, 2022

Last Update Submitted That Met QC Criteria

May 25, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

There is not a plan to make IPD data but when the statistical analysis of all data is made, all results will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Exercise

Subscribe